Tricuspid Regurgitation Clinical Trial
Official title:
Tricuspid Regurgitation Hamburg Cohort
Tricuspid regurgitation (TR) is frequent and has been directly related to high mortality rates. The pathophysiology of TR is mainly functional as it occurs predominantly in the context of left-sided heart disease, pulmonary hypertension, or atrial fibrillation. Surgery is currently the primary treatment option in patients with functional TR. However, isolated tricuspid valve surgery is associated with an intolerable high risk of operative mortality and poor outcomes. New transcatheter options could be used in high-surgical risk patients. However, with often severely dilated annuli with a non-planar and elliptical shape, absence of calcification, and proximity of structures, the tricuspid valve anatomy poses many challenges. Predictors of outcome are yet to be defined in patients with TR in order to improve risk prediction for the different treatment modalities (medical, surgical, interventional). The Tricuspid Regurgitation Hamburg Cohort (TRUTH) aims to monitor patients with relevant TR, irrespective of the underlying etiology or therapeutic approach. In addition to available evidence from previously published clinical trials, elaborate prospective clinical registries, such as TRUTH, that monitor clinical routine and current practice, will be of significant importance to further enhance therapeutic options.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05434507 -
Feasibility Study of Treating Tricuspid Regurgitation With K-ClipTM Transcatheter Annuloplasty System
|
N/A | |
Completed |
NCT03144024 -
Comparison of Rigid Annuloplasty Ring With a Band in the Correction of Secondary Tricuspid Insufficiency
|
N/A | |
Enrolling by invitation |
NCT05825898 -
Outcome of Patients With Severe Functional TR According to Medical, Transcatheter or Surgical Treatment
|
||
Completed |
NCT05836493 -
Very Long-term (>15 Years) Results of Tricuspid Valve Repair.
|
||
Enrolling by invitation |
NCT06033274 -
Global Multicenter Registry on Transcatheter TRIcuspid Valve RePLACEment
|
||
Recruiting |
NCT05671640 -
Feasibility Study of the DragonFly-T System for Severe Tricuspid Regurgitation
|
N/A | |
Recruiting |
NCT06027307 -
Enavogliflozin Outcome Trial in Functional Tricuspid Regurgitation
|
Phase 3 | |
Terminated |
NCT04665583 -
Prehab Prior to Undergoing Tricuspid Intervention
|
||
Recruiting |
NCT06307262 -
European Registry of Transcatheter Repair for Tricuspid Regurgitation
|
||
Completed |
NCT02981953 -
TRI-REPAIR: TrIcuspid Regurgitation RePAIr With CaRdioband Transcatheter System
|
N/A | |
Recruiting |
NCT04433065 -
TTVR Early Feasibility Study
|
N/A | |
Not yet recruiting |
NCT05556460 -
Safety and Effectiveness Study of DragonFly-T System for Severe Tricuspid Regurgitation
|
N/A | |
Recruiting |
NCT05667519 -
Prevention of Pacemaker Lead Induced Tricuspid regurgitAtion by Transesophageal eCho guidEd Implantation (PLACE)
|
N/A | |
Recruiting |
NCT04653428 -
German Registry for Transcatheter Tricuspid Valve Interventions
|
||
Recruiting |
NCT05179616 -
Pforzheim Tricuspid Valve Registry - Outcomes of Percutaneous Tricuspid Valve Repair
|
||
Completed |
NCT02644616 -
The Safety and Efficacy of Tolvaptan for Patients With Tricuspid Regurgitation and Right Heart Failure After Left Heart Valves Replacement
|
Phase 4 | |
Recruiting |
NCT05328284 -
PASCAL for Tricuspid Regurgitation - a European Registry
|
||
Completed |
NCT02675244 -
Evaluating the Benefit of Concurrent Tricuspid Valve Repair During Mitral Surgery
|
N/A | |
Recruiting |
NCT05436028 -
A Study to Evaluate the Safety and Performance of LuX-Valve Plus System for Tricuspid Replacement
|
N/A | |
Completed |
NCT01093001 -
Tricuspid Regurgitation Study
|
Phase 4 |